Local treatment vs. years of life lost in intermediate-risk prostate cancer
The role of radical prostatectomy (RP) or radiotherapy (RT) in intermediate-risk prostate cancer (PCa) is still under debate. Our aim was to quantify the effect of RP and RT on the average years of life lost (YLL) in patients with intermediate-risk PCa. Within the SEER database 2004–2021, intermediate-risk PCa patients...